Review Article
Epstein-Barr virus-associated lymphoproliferative disorders in immunosuppressed patients
Annals of Lymphoma
2021;
5:
24
(30 September 2021)
Review Article
Relapsed and refractory primary CNS lymphoma: treatment approaches in routine practice
Annals of Lymphoma
2021;
5:
23
(30 September 2021)
Review Article
Reframing Burkitt lymphoma: virology not epidemiology defines clinical variants
Annals of Lymphoma
2021;
5:
22
(30 September 2021)
Editorial
Preface: why this special series on marginal zone lymphomas?
Annals of Lymphoma
2021;
5:
21
(30 September 2021)
Review Article
Overcoming the blood-brain barrier in primary central nervous system lymphoma: a review on new strategies to solve an old problem
Annals of Lymphoma
2021;
5:
20
(30 June 2021)
Review Article
Narrative review: biomarkers, a hope towards early diagnosis in primary CNS lymphoma
Annals of Lymphoma
2021;
5:
19
(30 June 2021)
Review Article
Genetic heterogeneity in follicular lymphoma
Annals of Lymphoma
2021;
5:
18
(30 June 2021)
Review Article
Overview of the current treatment strategy in extranodal NK/T-cell lymphoma: from diagnosis to recurrence
Annals of Lymphoma
2021;
5:
17
(30 June 2021)
Review Article
Primary central nervous system lymphoma: epidemiology and clinical presentation
Annals of Lymphoma
2021;
5:
16
(30 June 2021)
Review Article
Positron emission tomography and magnetic resonance imaging in primary central nervous system lymphoma—a narrative review
Annals of Lymphoma
2021;
5:
15
(30 June 2021)
Review Article
Management of relapsed follicular lymphoma
Annals of Lymphoma
2021;
5:
14
(30 June 2021)
Review Article
Narrative review of primary central nervous system lymphoma: treatment-related neurotoxicity
Annals of Lymphoma
2021;
5:
13
(30 June 2021)
Review Article
Molecular insights into the pathogenesis of follicular lymphoma
Annals of Lymphoma
2021;
5:
12
(30 June 2021)
Review Article
Predicting early progression in follicular lymphoma
Annals of Lymphoma
2021;
5:
11
(30 June 2021)
Review Article
Frontline management for follicular lymphoma patients: a narrative review
Annals of Lymphoma
2021;
5:
10
(30 March 2021)
Review Article
Novel immunotherapy in follicular lymphoma: a narrative review
Annals of Lymphoma
2021;
5:
9
(30 March 2021)
Review Article
Primary central nervous system lymphoma: a narrative review of ongoing clinical trials and goals for future studies
Annals of Lymphoma
2021;
5:
8
(30 March 2021)
Review Article
Narrative review of chronic active EBV infection—advances in clinical management
Annals of Lymphoma
2021;
5:
7
(30 March 2021)
Review Article
Biology of splenic and nodal marginal zone lymphomas
Annals of Lymphoma
2021;
5:
6
(30 March 2021)
Review Article
Narrative review: secondary central nervous system lymphoma
Annals of Lymphoma
2021;
5:
5
(30 March 2021)
Review Article
Antibiotic treatment for bacteria-associated extranodal marginal zone lymphoma
Annals of Lymphoma
2021;
5:
4
(30 March 2021)
Review Article
Novel targeted agents for follicular lymphoma
Annals of Lymphoma
2021;
5:
3
(30 March 2021)
Review Article
Treatment of elderly patients with primary CNS lymphoma
Annals of Lymphoma
2021;
5:
2
(30 March 2021)
Review Article
The complex pathology and differential diagnosis of splenic and nodal marginal zone lymphoma
Annals of Lymphoma
2020;
4:
18
(30 December 2020)